Learn More
Description
EACA is reported to inhibit chymotrypsin, Factor VIIa, lysine carboxypeptidase, plasmin, and plasminogen activator. Reported to inhibit plasminogen binding to activated platelets. An early report indicated that it inhibits the activation of the first component of the complement system. Binds and inactivates Carboxypeptidase B.
Specifications
Specifications
| Melting Point | 205°C to 215°C |
| Density | 1.48g/mL (lit.) |
| Quantity | 5 kg |
| Solubility Information | Soluble in water (50mg/mL); sparingly soluble in alcohol and methanol; practically insoluble in ether; insoluble in ethanol. |
| Formula Weight | 131.2 |
| Physical Form | Powder |
Safety and Handling
| Recommended Storage | Room Temperature (15–30°C) |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.